Esperion Therapeutics Inc [ESPR] stock Downgrade by BofA Securities analyst, price target now $2.50
Esperion Therapeutics Inc [NASDAQ: ESPR] jumped around 0.3 points on Monday, while shares priced at $3.10 at the close of the session, up 10.71%. Compared to the average trading volume of 3.93M shares, ESPR reached a trading volume of 13816689 in the most recent trading